SHARE

Hair loss biotech Veradermics raises $256m in upsized US IPO

The late-stage clinical firm sold 15 million shares at $17 each, above its marketed range, giving it a market value of $596m. Its lead non-hormonal hair loss therapy is in late-stage trials, with shares set to trade under MANE.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.